EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Umbilical cord blood-derived CD133 positive cells for treatment of myocardial infarction

This study aims to test the potential of umbilical cord blood-derived CD133 cells in treating myocardial infarction. Umbilical cord blood-derived CD133 cells were isolated using magnetic activated cell sorting (MACS) and were infused into a myocardial infarction rat model. Treatment prevented scar thinning, attenuated systolic dilatation, and improved left ventricle function.
See additional Cell Therapies for: Heart
Umbilical cord blood-derived CD133 positive cells for treatment of myocardial infarction